Lyra B. Olson

956 total citations
16 papers, 407 citations indexed

About

Lyra B. Olson is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Lyra B. Olson has authored 16 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Lyra B. Olson's work include COVID-19 Clinical Research Studies (6 papers), RNA Interference and Gene Delivery (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Lyra B. Olson is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), RNA Interference and Gene Delivery (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Lyra B. Olson collaborates with scholars based in United States, Japan and Argentina. Lyra B. Olson's co-authors include Elise C. Cope, Elizabeth A. LaMarca, Susana Rodríguez, Elizabeth Gould, Patrick K. Monari, Nicole Katchur, Anna D. Zych, Bruce A. Sullenger, Kristin Corey and Jean M. Connors and has published in prestigious journals such as Advanced Materials, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Lyra B. Olson

15 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyra B. Olson United States 10 125 101 70 67 63 16 407
M.-A. Dommergues France 9 93 0.7× 110 1.1× 99 1.4× 64 1.0× 22 0.3× 28 573
Lynnae Schwartz United States 10 168 1.3× 102 1.0× 66 0.9× 47 0.7× 33 0.5× 14 482
Clara Erice United States 10 146 1.2× 96 1.0× 60 0.9× 59 0.9× 35 0.6× 20 432
Rianne Haarsma Netherlands 3 79 0.6× 71 0.7× 76 1.1× 16 0.2× 94 1.5× 3 371
Justin Cohen United States 8 146 1.2× 194 1.9× 59 0.8× 29 0.4× 186 3.0× 8 461
Nazanin Ghazanfari Australia 13 205 1.6× 68 0.7× 83 1.2× 97 1.4× 50 0.8× 15 661
Crystal Bethel‐Brown United States 10 140 1.1× 147 1.5× 65 0.9× 47 0.7× 38 0.6× 15 425
Kiarash Saleki Iran 18 283 2.3× 95 0.9× 153 2.2× 136 2.0× 52 0.8× 46 851
Robert J. Kahoud United States 10 159 1.3× 87 0.9× 38 0.5× 107 1.6× 37 0.6× 19 584
Valeriya Avdoshina United States 14 165 1.3× 151 1.5× 41 0.6× 54 0.8× 89 1.4× 16 534

Countries citing papers authored by Lyra B. Olson

Since Specialization
Citations

This map shows the geographic impact of Lyra B. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyra B. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyra B. Olson more than expected).

Fields of papers citing papers by Lyra B. Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyra B. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyra B. Olson. The network helps show where Lyra B. Olson may publish in the future.

Co-authorship network of co-authors of Lyra B. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Lyra B. Olson. A scholar is included among the top collaborators of Lyra B. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyra B. Olson. Lyra B. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chabata, Charlene V., James W. Frederiksen, Lyra B. Olson, et al.. (2022). Combining Heparin and a FX/Xa Aptamer to Reduce Thrombin Generation in Cardiopulmonary Bypass and COVID-19. Nucleic Acid Therapeutics. 32(3). 139–150. 6 indexed citations
2.
Olson, Lyra B., et al.. (2022). Targeting DAMPs with nucleic acid scavengers to treat lupus. Translational research. 245. 30–40. 9 indexed citations
3.
Olson, Lyra B., Rachel E. Rempel, Haixiang Yu, et al.. (2022). Mixed-surface polyamidoamine polymer variants retain nucleic acid-scavenger ability with reduced toxicity. iScience. 25(12). 105542–105542. 2 indexed citations
4.
Yu, Haixiang, et al.. (2022). Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples. Cell chemical biology. 29(2). 215–225.e5. 10 indexed citations
5.
Naqvi, Ibtehaj A., Nicholas Giroux, Lyra B. Olson, et al.. (2022). DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists. Biomaterials. 283. 121393–121393. 52 indexed citations
6.
Özer, İmran, George A. Pitoc, Juliana M. Layzer, et al.. (2022). PEG‐Like Brush Polymer Conjugate of RNA Aptamer That Shows Reversible Anticoagulant Activity and Minimal Immune Response. Advanced Materials. 34(10). e2107852–e2107852. 32 indexed citations
7.
Corey, Kristin, Lyra B. Olson, Ibtehaj A. Naqvi, et al.. (2022). Suppression of Fibrinolysis and Hypercoagulability, Severity of Hypoxemia, and Mortality in COVID-19 Patients: A Retrospective Cohort Study. Anesthesiology. 137(1). 67–78. 7 indexed citations
8.
Mohan, Aditya, Lyra B. Olson, Ibtehaj A. Naqvi, et al.. (2022). Age and Comorbidities Predict COVID-19 Outcome, Regardless of Innate Immune Response Severity: A Single Institutional Cohort Study. Critical Care Explorations. 4(12). e0799–e0799. 2 indexed citations
9.
Olson, Lyra B., Rachel E. Rempel, Jeffrey I. Everitt, et al.. (2021). β-Cyclodextrin-containing polymer treatment of cutaneous lupus and influenza improves outcomes. Molecular Therapy. 30(2). 845–854. 9 indexed citations
10.
Heggestad, Jacob T., David Kinnamon, Daniel Y. Joh, et al.. (2021). Rapid test to assess the escape of SARS-CoV-2 variants of concern. Science Advances. 7(49). eabl7682–eabl7682. 20 indexed citations
11.
Levy, Jerrold H., Toshiaki Iba, Lyra B. Olson, et al.. (2021). COVID‐19: Thrombosis, thromboinflammation, and anticoagulation considerations. International Journal of Laboratory Hematology. 43(S1). 29–35. 40 indexed citations
12.
13.
Olson, Lyra B., et al.. (2019). Streptococcus salivarius Prosthetic Joint Infection following Dental Cleaning despite Antibiotic Prophylaxis. SHILAP Revista de lepidopterología. 2019. 1–4. 8 indexed citations
14.
Cope, Elise C., Elizabeth A. LaMarca, Patrick K. Monari, et al.. (2018). Microglia Play an Active Role in Obesity-Associated Cognitive Decline. Journal of Neuroscience. 38(41). 8889–8904. 169 indexed citations
15.
Cope, Elise C., Maya Opendak, Elizabeth A. LaMarca, et al.. (2018). The effects of living in an outdoor enclosure on hippocampal plasticity and anxiety‐like behavior in response to nematode infection. Hippocampus. 29(4). 366–377. 16 indexed citations
16.
Qian, Xiaolan, Marian E. Durkin, Dunrui Wang, et al.. (2012). Inactivation of the Dlc1 Gene Cooperates with Downregulation of p15INK4b and p16Ink4a , Leading to Neoplastic Transformation and Poor Prognosis in Human Cancer. Cancer Research. 72(22). 5900–5911. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.-A. Dommergues Breakdown of academic impact, for papers by Lynnae Schwartz Breakdown of academic impact, for papers by Clara Erice Breakdown of academic impact, for papers by Rianne Haarsma Breakdown of academic impact, for papers by Justin Cohen Breakdown of academic impact, for papers by Nazanin Ghazanfari Breakdown of academic impact, for papers by Crystal Bethel‐Brown Breakdown of academic impact, for papers by Kiarash Saleki Breakdown of academic impact, for papers by Robert J. Kahoud Breakdown of academic impact, for papers by Valeriya Avdoshina
Rankless by CCL
2026